Superworth

OptimizeRx OPRX

Financial - Credit Services, Financial Services
$9.41
+0.97%
Market cap
$177.2M
PE
39.2×
7y median 33.0×
Forward PE
n/m
not a meaningful number
Price to sales
1.8×
EV/EBIT
15.8×
Revenue, 12 months
$98.7M
−6% on a year ago
Net margin
4.7%
Free cash flow yield
10.4%

OptimizeRx trades at 39.2× trailing earnings, pricier than 65% of the last ten years. Revenue was $98.7M over the last twelve months, down 6% on a year earlier with a 5% net margin.

Charts

Financials

Income statement for OPRX, by quarter
Income statementQ3 FY23Q4 FY23Q1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
$16.3M+8%$28.4M+44%$19.7M+51%$18.8M+36%$21.3M+31%$32.3M+14%$21.9M+11%$29.2M+55%$26.1M+22%$32.2M−0%$19.8M−10%$20.5M−30%
Cost of revenue$6.5M+15%$10.5M+46%$7.5M+34%$7.1M+19%$7.9M+20%$10.3M−2%$8.6M+15%$10.6M+49%$8.6M+9%$8.1M−21%$4.9M−43%$4.8M−54%
Gross profit$9.8M+4%$17.8M+43%$12.2M+64%$11.7M+50%$13.4M+37%$22M+23%$13.3M+9%$18.6M+59%$17.5M+30%$24.1M+9%$14.9M+12%$15.7M−16%
R&Dn/an/an/an/an/an/a$3.3M$3.1Mn/an/a$3.4M+5%$3.3M+6%
SG&A$12.9M+2%n/a$16.2M+15%$14.4M+18%$13.4M+4%n/a$9.5M−41%$9.8M−32%$14.4M+7%n/a$8.2M−14%$9.2M−6%
−$3.6M−5%−$10.9M+1161%−$5M−29%−$3.7M−23%−$8.6M+141%$3.6M−$2.1M−58%$3.2M$2M$8.6M+136%$396K−$88K
Interest expensen/an/a$1.5M$1.5M$1.5M$1.6M$1.3M−16%$1.6M+5%$1.2M−24%$1.2M−21%$1.2M−11%$1.1M−30%
Pre-tax income−$2.9M−17%−$11.7M+3503%−$6.6M+3%−$5.1M+23%−$9.9M+247%$2.2M−$3.3M−50%$1.7M$1M$7.5M+238%−$644K−80%−$1.1M
n/an/a$344K−$1.1M−$817K$2.3M−$1.1M$199K$270K$2.5M+7%−$149K−86%−$393K
Net income−$2.9M−17%−$4.1M+1171%−$6.9M+8%−$4M−4%−$9.1M+218%−$78K−98%−$2.2M−68%$1.5M$779K$5M−$495K−78%−$703K
−$0.17−11%−$0.23+1050%−$0.38+3%−$0.22−8%−$0.50+194%$0.00−$0.12−68%$0.08$0.04$0.27−$0.03−75%−$0.04
16.6M−8%17.8M+4%18.2M+6%18.3M+7%18.3M+10%18.4M+4%18.5M+2%19M+4%19.5M+6%18.9M+3%18.8M+2%18.8M−1%

Gross profit: Q1 FY26 and Q2 FY26: not printed by the filing, worked out from its own lines.

EPS, diluted: 10 periods, Q4 FY16 to Q4 FY25: quarter's net income to common over its shares, to the cent.

Diluted shares: 3 periods, Q4 FY12 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY13: share-days: the 12-month average over 365 days less the 9-month over 273, the two on one basis (x1.441). 7 periods, Q4 FY16 to Q4 FY24: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY21: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Financial - Credit Services nearest OptimizeRx's size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
OPRXOptimizeRx$177.2M39.2×33.0×1.8×−6%4.7%
DHXDHI$207.6M159×31.6×1.7×−7%1.0%
CPSSConsumer Portfolio Services$218.7M9.8×6.1×0.5×+10%5.0%
SNFCASecurity National Financial$254.1M6.4×5.8×0.8×−1%11.1%
POWWOutdoor$279.6M80.3×21.7×5.2×+10%6.4%
IMXIInternational Money Express$287.6M15.1×14.9×0.5×−14%3.4%
IRHOIron Horse Acquisition II$296M67.3×67.2×n/mn/mn/m
LSAKLesaka Technologies$346.7M101×7.9×0.5×+9%0.4%
RMRegional Management$350.8M7.9×9.1×0.5×+8%7.0%
TREELendingTree$380.2M2.2×68.2×0.3×+25%14.3%
MACIMelar Acquisition Corp. I/Cayman$72.6M44.8×54.4×n/mn/mn/m
Peer median$283.6M29.9×18.3×0.5×+9%5.7%

More on OptimizeRx

Each number over time

Its groups

About

Industry
Financial - Credit Services
Sector
Financial Services

Valuation data, not investment advice. Prices as of .